Collaborative Oncology: Uniting in Reduction of Adverse Events
October 15, 2020
Learning Objectives
- Describe the role of and scientific basis for hypofractionated radiation therapy
- Describe the common inflammatory adverse events of immunotherapy and its management through case based examples
- Discuss the challenges of endocrine-oncology adverse events related to immunotherapy
- Discuss the development, measurement and sustainability of survivorship programs in the oncology practice
- Identify the need for early implementation of palliative services in the oncology patient's care continuum
Course summary
Available credit:
- 3.00 ACPE - Pharmacist
- 3.00 ACPE - Pharmacy Technician
- 3.00 AMA PRA Category 1 Credit(s)™
- 3.00 ANCC
- 3.00 Attendance
- 3.00 JA Credit - AH
- 3.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens:
10/15/2020
Registration Expires:
10/14/2021
Activity Starts:
10/15/2020 - 4:00pm EDT
Activity Ends:
10/15/2020 - 7:30pm EDT
Add to calendar:
Duke Health/Augusta Health
Durham, NC
27708
United States
Available Credit
- 3.00 ACPE - Pharmacist
- 3.00 ACPE - Pharmacy Technician
- 3.00 AMA PRA Category 1 Credit(s)™
- 3.00 ANCC
- 3.00 Attendance
- 3.00 JA Credit - AH
- 3.00 Approved for AMA PRA Category 1 Credit(s)™

Facebook
X
LinkedIn
Forward